-
Pivotal announces participation in two clinical trials with a novel investigational immunotherapy drug to treat melanoma and lung cancer
-
Impressions from the visit to Wageningen, the specter of famine, CRISPR Cas9 to the rescue!
-
Reach out to potential partners and customers in the Danish-Swedish life science cluster, Medicon Valley
-
Central European Healthcare Expo (20-21.05.2020 Global Expo Warsaw)
The world of healthcare ...
All articles
/
3
2014-12-09
The only hope for central nervous system disorder patients
Stem cells have been already applied both in research and clinical trials seeking for new therapies of diseases affecting the central nervous system. Although they have long been a subject of ethical discussions, their potential in neuroscience research is constantly growing.... Read more
Tags nanotechnologia , pharma
2013-03-22
Are diseases sexist?
Sexism accompanied mankind since the very beginning and is one of the most difficult stereotypes to eradicate. Traditional gender-roles as well as widely-shared cultural believes present men as more competent and socially valued than women in numerous activities. Even the medical research has been f... Read more
Tags pharma , pharmaceutical , sexism , diseases
2013-03-04
to
2013-03-08
SMEs – the driving force of pharma industry in European Union
Recently, European Medicines Agency (EMA) has presented annual report from the SME office 2012 summering outcomes of 7 years of Small and Medium-Sized Enterprises (SMEs). According to it, in 2012, the number of companies assigned as SME status increased by 62% compared to previous year proving rapid... Read more
Tags pharma , europe , SMEs , EMA
“Speed of growth is a difficult balance” - The interview with Michael Globits, Business Operations Manager of HungaroTrial
HungaroTrial is a leading CRO in the CEE region, providing services for Phase 1 through Phase 4 clinical trials. The organization was founded in Hungary in 1999 by Dr. Lajos Sárosi and has successfully expanded its activities into such countries as Czech Republic, Slovakia, Romania, Serbia, Croatia, ... Read more
Tags medicine , pharma , interview , hungary
2013-02-25
to
2013-02-27
Clinical research in CEE as an alternative for the global business
The importance of clinical research for developing biotechnological global business is absolutely unquestionable. That is an only way to transform medical and scientific inventions into useful and effective products - pharmaceuticals. But whether Central and Eastern Europe countries could be alternat... Read more
Tags bioforum , medicine , events , pharma
Short overview of clinical trials in Lithuania
Lithuania is treated as a favorable and friendly environment for clinical research. Since Lithuania had joined the European Union, the legislation process was harmonized with the EU’s regulations. With a short approval time and positive attitude of patients towards CR, Lithuania is an attractive plac... Read more
Tags medicine , pharma , lithuania
Consequences of the Macedonian healthcare reform and pharmaceutical tourism
In 2006 the Macedonian health sector was reformed. The core aim of the policy was to diminish the inequities in the health care provision in the point of drug delivery by reducing, for instance, out-of-pocket expenditures. The main objectives of the reform were to improve the supply of medicines, as ... Read more
Tags pharma , macedonia
2013-02-20
to
2013-02-22
Mabion targets Bosnia
Mabion SA submitted in Bosnia full set of R&D and legal documents in order to register clinical trials of MabionCD20 medicine, which is used in therapy of blood cancers and rheumatoid arthritis (RA). The application was delivered to 6 bioethical commissions in Bosnia and in the Council of Registratio... Read more
Tags poland , pharma , europe , bosnia
Health, beauty, potency… - How do we make a decision which supplement to choose?
Over-the-counter products (OTC), the medicines, which can be bought without the need to have a prescription, constitute a substantial share of the pharmaceutical market. In the moment we enter the pharmacy, the battle between the drugs’ producers to target us as their clients commences. What are the ... Read more
Tags medicine , pharma , europe , romania
Russia: Petrov’s Institute collaborates with Astra Zeneca
Petrov Research Institute of Oncology is one of the oldest such places in Russia. Its broad experience in cancer research interested one of the biggest players on pharma market - Astra Zeneca.... Read more
Tags medicine , pharma , russia
2013-02-11
to
2013-02-13
CPS Cortex Ltd. – interview with István Szemerédi, General Manager
CPS Cortex Contract Research Organization was founded in 2005 with the aim of becoming one of the most reliable partners of Hungarian and international pharmaceutical companies, CROs, universities, hospitals and other health institutions in the planning and conduct of clinical trials from the beginni... Read more
Tags bioforum , biotechnology , pharma , interview , hungary
Success story of Vela Labs - an interview with Dr. Andreas Nechansky - part 2
A second part of an interview with Dr. Andreas Nechansky - one of the founders of Vela Laboratories. This time about BioForum, summary of 2012 and about biotech in CEE.... Read more
Tags bioforum , austria , pharma , interview
Success story of Vela Labs - interview with Dr. Andreas Nechansky – part 1
Andreas Nechansky is one of the founders of Vela Laboratories, which is an Austrian company covering analytical development, quality control, qualification, validation, research and development and other aspects of biotech.... Read more
Tags bioforum , austria , pharma , interview
2013-02-07
Tough times for Hungarian pharmaceutical companies? – The implementation of the new system of high-cost medicines reimbursement
On 31st January 2013, the decree concerning the new system of expensive biological medicines reimbursement was published. The regulation is a milder version of controversial plans of Hungarian government to limit the end-of-life treatment of cancer patients.The State Secretariat for Healthcare (EMMI... Read more
Tags pharma , hungary
2013-02-01
An interview with Prof. Gerhard Krejci PhD, HonD – CEO of Clinical Investigations Ltd.
Clinical Investigations Group is a company providing full-service in Clinical Trials Phase I to IV in Hungary, Romania, Bulgaria, Poland and Czech and Slovak Republic, working only with local monitors, mostly physicians and pharmacists. Taking advantage from the ready cooperation from investigators w... Read more
Tags biotechnology , pharma , interview , hungary
2013-01-21
to
2013-01-24
New Novo Nordisk diabetes drugs gain EC approval
Novo Nordisk drugs for the treatment of diabetes in adults - Tresiba® (insulin degludec) and Ryzodeg® (insulin degludec/insulin aspart), has been granted European Commission’s approval across all EU member states.... Read more
Tags medicine , pharma , europe
Tredaptive, Pelzont and Trevaclyn suspended from the EU market
The European Medicines Agency (EMA) supported their previous opinion to suspend Tredaptive, Pelzont and Trevaclyn from the market (editor note: Pelzont is the brand name of Tredaptive in Italy and Trevaclyn in Italy and Portugal). Those nicotinic acid/laropirant based drugs were used for treatment of... Read more
Tags pharma , europe
PHARM Connect: Pharma and Biotech professionals of CEE getting together for further industry growth in the region
Central and Eastern Europe is a rapidly emerging market for pharmaceutical manufacturing and distribution, and at the same time countries of the region are becoming hot-spots for research with many universities, research institutes and biotechnology companies being present. On the other hand, compani... Read more
Tags events , pharma , hungary
2013-01-14
to
2013-01-18
2nd Annual Pharma Law Convention this time in Prague!
2nd edition of Pharma Law Convention organized in partnership with The Association of Innovative Pharmaceutical Industry is held in Prague, Czech Republic on 13-14 of March 2013. Its mission is to bring pharmaceutical industry of Central and Eastern Europe together with experts from European regulat... Read more
Tags czech republic , events , pharma